Dr. Regina Rabinovich Succeeds Dr. Axel Hoos as Sabin Vaccine Institute Board Chair, Drs. Norman Baylor and JoAnn Suzich Join the Board

NEXT STORY
Sandoz Canada receives authorization from Health Canada to launch new biosimilar Hyrimoz® (adalimumab)
PREV STORY
Tiziana Life Sciences PLC (“Tiziana” or “the Company”) – Notification of proposed admission to the Main Market and cancellation of trading on AIM
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

author_avatar
NASDAQ Market News

Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema

-  In the pivotal study, patients taking TAKHZYRO 300 mg every 2 weeks had an ...

author_avatar
NASDAQ Market News

Augmenta Bioworks and TFF Pharmaceuticals Announce Selection of Lead Monoclonal Antibody Candidate AUG-3387 for Clinical Development Against COVID-19

author_avatar
NASDAQ Market News